
FBB Biomed is a U.S. veteran-owned biotech company based in Coralville, Iowa, specializing in precision neurology diagnostics through a proprietary AI-powered RNA platform. The company develops a research-use-only blood test that leverages RNA as a biological operating system to monitor neurologic health and disease over a lifetime. Their technology integrates with existing genomic sequencing infrastructure, enabling personalized diagnostics and therapeutics based on ancestral genes. FBB Biomed has transitioned from R&D to commercial operations, partnering with CLIA & CAP-certified labs to offer their tests, and holds patents covering methods for classifying, detecting, and treating biological diseases. The company collaborates with universities, research institutes, and diagnostic companies, positioning itself as a pioneer in liquid biopsy for neurology with broad applications in human, veterinary, and agricultural health markets.

FBB Biomed is a U.S. veteran-owned biotech company based in Coralville, Iowa, specializing in precision neurology diagnostics through a proprietary AI-powered RNA platform. The company develops a research-use-only blood test that leverages RNA as a biological operating system to monitor neurologic health and disease over a lifetime. Their technology integrates with existing genomic sequencing infrastructure, enabling personalized diagnostics and therapeutics based on ancestral genes. FBB Biomed has transitioned from R&D to commercial operations, partnering with CLIA & CAP-certified labs to offer their tests, and holds patents covering methods for classifying, detecting, and treating biological diseases. The company collaborates with universities, research institutes, and diagnostic companies, positioning itself as a pioneer in liquid biopsy for neurology with broad applications in human, veterinary, and agricultural health markets.